Kakkar; Rahul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kakkar; Rahul.The latest application filed is for "methods for treating il-6 mediated inflammation without immunosuppression".

Company Profile

3.3.10

Kakkar; Rahul - Weston MA
Kakkar; Rahul - Waltham MA
Kakkar; Rahul - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression App 20220227856 - Devalaraja; Madhav N. ; et al.	2022-07-21
Methods for treating IL-6 mediated inflammation without immunosuppression Grant 11,384,143 - Devalaraja , et al. July 12, 2	2022-07-12
Treatment of existing left ventricular heart failure App 20220195033 - TESTANI; Jeffrey ; et al.	2022-06-23
Treatment of existing left ventricular heart failure Grant 11,203,636 - Testani , et al. December 21, 2	2021-12-21
Methods For Treating Hepcidin-mediated Disorders App 20210292405 - KAKKAR; Rahul ; et al.	2021-09-23
Treatment of Diuretic Resistance App 20200079846 - TESTANI,; Jeffrey ; et al.	2020-03-12
Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression App 20190248886 - Devalaraja; Madhav N. ; et al.	2019-08-15
Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression App 20190241650 - Devalaraja; Madhav N. ; et al.	2019-08-08
Nk3 Receptor Antagonist Compound (nk3ra) For Use In A Method For The Treatment Of Polycystic Ovary Syndrome (pcos) App 20170157109 - Gilmour; Peter Stewart ; et al.	2017-06-08
Methods For Treating Hepcidin-mediated Disorders App 20170029499 - Kakkar; Rahul ; et al.	2017-02-02
NK3 receptor antagonist compound (NK3RA) for use in a method for the treatment of polycystic ovary syndrome (PCOS) Grant 9,475,773 - Gilmour , et al. October 25, 2	2016-10-25
Systems And Methods For Digital Predictive Disease Exacerbation And Pre-emptive Treatment App 20160089089 - Kakkar; Rahul ; et al.	2016-03-31
A Nk3 Receptor Antagonist Compound (nk3ra) For Use In A Method For The Treatment Of Polycystic Ovary Syndrome (pcos) App 20160083350 - Gilmour; Peter Stewart ; et al.	2016-03-24

Company Registrations

SEC

0001817416

Kakkar Rahul

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.